公司资料
Oncolytics Biotech Inc. 股价、新闻与催化剂
- 股票代码:
- ONCY
- 交易所:
- NASDAQ
- 行业:
- Biopharma
- 所在地:
- Canada and listed in the U
股票表现
0.82 USD (-1.35%)
收盘价
最后更新: 2026年8月17日
111M USD
市值
股价为何变动
The latest monitored company update is “Oncolytics Biotech® Aligns with FDA on Registrational Path for Second-Line RAS-Mutant MSS Colorectal Cancer.” The corresponding closing-price reaction is not yet available.
公司概览
业务概览
Oncolytics Biotech is an oncology company focused on oncolytic virus therapy and immune activation in cancer. Its story is built around using a viral platform to trigger stronger anti-tumor responses in difficult solid tumors.
所在地与行业分类
Oncolytics is headquartered in Canada and listed in the U.S. market. It sits in small-cap oncology biotechnology.
商业模式特征
The company depends on clinical validation, translational confidence, and capital support while it develops a narrow cancer platform. Investors usually watch efficacy, safety, and partnership interest.
生物医药行业定位
Oncolytics occupies a specialized oncolytic-virus niche within biotech. The stock is catalyst-sensitive because the market still needs proof that the platform can create durable clinical value.
未来催化剂
- Oncolytics’ catalysts are pelareorep and the oncology-combination program, where the next clinical update can materially move the stock. The company remains highly dependent on human data.
近期新闻
- 01
- 02
- 03
- 04
- 05
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。